Skip to main content

LumiraDx goes public as $3B “De-SPAC” merger with CA Healthcare closes

Press releases | September 30, 2021

Fried Frank advised LumiraDx, a next generation point-of-care diagnostics company, on its merger with CA Healthcare Acquisition Corp., a blank-check special acquisition company (SPAC). LumiraDx is now listed on Nasdaq. 

The "De-SPAC" transaction values the enlarged LumiraDx group in excess of US$3 billion. This transaction will drive LumiraDx's pipeline of 30+ assays across common health conditions including infectious disease, cardiovascular disease, diabetes, and coagulation disorders to address a US$50+ billion global market opportunity.

The LumiraDx platform is being used by CVS Pharmacy, Inc. in the US, the National Health Service and Boots in the UK, a significant number of accident and emergency rooms in Italy and other parts of Europe, hospital systems in Japan and across South America, and is being deployed in partnership with the Bill & Melinda Gates Foundation in a growing number of African countries where access to high quality diagnostics is limited. In the 12 months prior to the announcement of the merger, this was the largest "De-SPAC" transaction announced, according to Bloomberg.   

As a result of the transaction, Fried Frank has been shortlisted in the Transatlantic Corporate Team of the Year category for The Lawyer Awards 2021.

The Fried Frank team was led by corporate partners Ian Lopez and Warren S. de Wied, and included tax partners Joseph E. Fox, Alan S. Kaden, and Nick Thornton; executive compensation & ERISA partner Jason R. Ertel; corporate partner Neil Caddy; litigation partner Scott B. Luftglass; corporate associates Nick Skill, James Frecknall, Ryan T. Fung, Sarah Goodwin, Nina Marot, Adrian Packer, Andrew Steiger, Jacqueline Punjabi, and Sophie Tenn; executive compensation & ERISA associate Samantha Steinfeld Rozell; tax associates Thomas Bramall, Shane C. Hoffmann, and Richard Pilgrim; trainee associates Amal Awad, Yolanda Chan, Natalia Ivanova, and Indre Kazlauskaite; tax law clerk Michael Stepan; and executive compensation & ERISA law clerk Michael White.
.


This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.